All Stories

  1. Relationship between plasma apolipoprotein B concentrations and LDL particle number
  2. Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD
  3. Effect of ABT-335 (fenofibric acid) on meal-induced oxidative stress in patients with metabolic syndrome
  4. Children with NAFLD Are More Sensitive to the Adverse Metabolic Effects of Fructose Beverages than Children without NAFLD
  5. Changes in Lipoprotein-associated Phospholipase A2 with Ezetimibe/Simvastatin Co-administered with ER Niacin in Type II Hyperlipidemia
  6. Changes in Lipoprotein Particle Number with Ezetimibe/Simvastatin Co-administered with Extended-Release Niacin in Patients with Type II Hyperlipidemia†
  7. Reduced arterial compliance in patients with psychiatric diagnoses
  8. INFLAMMATORY AND LIPID MARKERS PRE- AND POST-LDL APHERESIS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (THE INFLAME STUDY)
  9. Lipoproteins as biosensors of endothelial oxidative status
  10. The differential effect of statins on oxidative stress and endothelial function: Atorvastatin versus pravastatin
  11. Substitution of Standard Soybean Oil with Olive Oil-Based Lipid Emulsion in Parenteral Nutrition: Comparison of Vascular, Metabolic, and Inflammatory Effects
  12. Cardiovascular Complications in CKD Patients: Role of Oxidative Stress
  13. Triglyceride-Rich Lipoproteins
  14. 112: Increased Oxidative Susceptibility of Low Density Lipoprotein (LDL) After Standard Hemodialysis Procedure
  15. Beneficial effects of designed dietary fatty acid compositions on lipids in triacylglycerol-rich lipoproteins among Chinese patients with type 2 diabetes mellitus
  16. Oxidized lipids and lipoproteins: indices of risk or targets for management
  17. Cholesterol: Concentration, Ratio, and Particle Number
  18. Hyperlipidemia and cardiovascular disease: cardiovascular update
  19. Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress
  20. Reducing oxidized lipids to prevent cardiovascular disease
  21. Heritability of carotid intima-media thickness: A twin study
  22. Cardiovascular disease
  23. Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive protein
  24. The role of hypertriglyceridemia in atherosclerosis
  25. Intrinsic enzymes of high-density lipoprotein
  26. Hyperlipidemia and cardiovascular disease
  27. Relations of Body Fatness and Cardiovascular Fitness to Lipid Profile in Black and White Adolescents
  28. Comparison of the Relation of Triglyceride-Rich Lipoproteins and Muscular Artery Compliance in Healthy Women Versus Healthy Men
  29. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes
  30. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: Associations with lipoprotein subclasses
  31. Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease
  32. Atherogenic lipid profiles in Filipino adolescents with low body mass index and low dietary fat intake
  33. Triglyceride-Rich Lipoproteins
  34. Small, dense low-density lipoprotein: Risk or myth?
  35. Long-term effect of reduced carbohydrate or increased fiber intake on LDL particle size and HDL composition in subjects with type 2 diabetes
  36. Physical training improves insulin resistance syndrome markers in obese adolescents
  37. Hyperlipidaemia and cardiovascular disease
  38. Hyperlipidaemia and cardiovascular disease
  39. Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium
  40. Visceral Adipose Tissue and Markers of the Insulin Resistance Syndrome in Obese Black and White Teenagers
  41. Hyperlipidaemia and cardiovascular risk factors
  42. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: Effect of triglyceride reductions with atorvastatin
  43. Triglyceride-Rich Lipoproteins
  44. Hyperlipidaemia and cardiovascular disease
  45. Visceral adipose tissue and cardiovascular risk factors in obese children
  46. Kinetics of retinyl esters during postprandial lipemia in man: A compartmental model
  47. Hyperlipidemia and cardiovascular disease
  48. Hyperlipidaemia and cardiovascular disease
  49. Concentrations of Lp(a) in black and white young adults: Relations to risk factors for cardiovascular disease
  50. Cardiovascular disease and hyperlipidaemia
  51. Effect of acute intravenous alcohol on plasma lipoprotein in man
  52. Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liver
  53. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol
  54. Evidence for heterogeneity of low-density lipoprotein metabolism in the cynomolgus monkey
  55. Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia
  56. Kinetic analysis using specific radioactivity data
  57. Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography
  58. Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for Acne
  59. Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: A saturable pathway distinct from the LDL receptor
  60. Lipoprotein Metabolism during Acute Inhibition of Hepatic Triglyceride Lipase in the Cynomolgus Monkey
  61. Compartmental Models for the Study of Apoprotein B Catabolism in Man
  62. A Reduced Model for Very Low Density Lipoprotein Triglyceride Metabolism
  63. Effect of a high carbohydrate diet on apoprotein-B catabolism in man
  64. Risk Factors